Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Finasteride can cause depression, suicidal thoughts, and lasting psychiatric and sexual issues.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Early-onset male baldness may increase the risk of metabolic syndrome.

Many dermatologists believe finasteride can cause sexual side effects and counsel patients about them.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Titanium dioxide nanoparticles may harm the male reproductive system.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Treatment during development affects hormone balance and sexual behavior in male rats.

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Topical minoxidil effectively promotes hair regrowth in male pattern baldness.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

CG2001 is safe and well-tolerated for treating hair loss in men.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Hair loss link to severe COVID-19 unclear.